Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service
about
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissueMephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake ratsHere today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazinesCathinone neurotoxicity ("The "3Ms")Ethylone-Related Deaths: Toxicological FindingsMephedrone and nicotine: oxidative stress and behavioral interactions in animal modelsThe preclinical pharmacology of mephedrone; not just MDMA by another name.Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineMonitoring a toxicological outbreak using Internet search query data.Using poisons information service data to assess the acute harms associated with novel psychoactive substances.Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.Emerging drugs of abuse: current perspectives on substituted cathinones.Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology.Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs.In vitro metabolism studies on mephedrone and analysis of forensic cases.Behavioral pharmacology of designer cathinones: a review of the preclinical literatureSynthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedrone.Posterior reversible encephalopathy syndrome (PRES) complicating the 'legal high' mephedrone.Synthetic cathinones: a new public health problemBath salts: the ivory wave of trouble.3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions.Psychosis associated with acute recreational drug toxicity: a European case series.Synthetic cathinones ('bath salts'): legal and health care challenges.Psychoactive "bath salts": not so soothing.Acute kidney injury requiring haemodialysis following ingestion of mephedrone.Severe Psychosis, Drug Dependence, and Hepatitis C Related to Slamming Mephedrone.Pneumomediastinum secondary to mephedrone inhalationSynthetic cathinone abusePhase I metabolites of mephedrone display biological activity as substrates at monoamine transporters.Bath salts and synthetic cathinones: an emerging designer drug phenomenon.Bath salts: a newly recognized cause of acute kidney injury.Mephedrone inhalation causes pneumomediastinum.Effects and risks associated with novel psychoactive substances: mislabeling and sale as bath salts, spice, and research chemicals.Synthetic cathinones (bath salts): legal status and patterns of abuse.Methylenedioxypyrovalerone ("bath salts"), related death: case report and review of the literature.Khat and synthetic cathinones: a review."Not for human consumption": a review of emerging designer drugs.Toxicology and management of novel psychoactive drugs.Bath Salt-Induced Psychosis: Nursing Assessment, Diagnosis, Treatment, and Outcomes.Bibliometric analysis of poison center-related research published in peer-review journals.
P2860
Q24615008-3E2D1C0A-AA31-4CDE-BA5B-18E752104510Q24617723-8F386A90-237C-4D95-B3C5-2422A8540342Q24631675-61CDE095-EFD6-495D-9251-29D97845A214Q26828641-2DA7A204-34C5-467E-A2B5-F0DC46CADC81Q28262614-D4BB5693-1FCC-41E6-AD53-DCA3E8DE9003Q28393490-D58C112D-A390-4585-BD30-76AE7263B8F3Q30412911-294DA2D4-9386-4942-9234-8559EB2DCDEEQ30417935-4FC74638-8B0C-430D-9146-4785ABB24FD3Q30570562-ACADA858-D7A6-4FD6-A089-A66E7B805751Q30821795-503458D5-C4BE-4AD0-A555-964C3CD9BFD0Q30866147-55D9939B-4648-45CF-A0DF-555EE6021B94Q33706892-1B1FD533-298A-48B6-9318-D30AC21D9CC8Q33934379-09395836-BC7C-461E-B3AA-2B0A6B16F3C8Q34267407-D8501387-9106-4F55-8CAE-74B19CF1E45CQ34273882-6E3888A5-C78E-48DD-89B4-B3F7E955B084Q34385074-89A52970-0941-4D14-AEF2-90F9AF1B1948Q34537347-FD0CE49A-3D69-4A6A-BFF6-A20D62434892Q35195168-5A95577C-E7F1-446A-8615-17657789868BQ35710543-807EC58C-D77C-4935-B77A-BC0AB22928C8Q35817281-E4ECC668-2FB5-4AE9-AB73-03D268839981Q35871216-D6BE73A0-4FED-4B64-8B40-0FB3C1C3B191Q36107475-0F101A78-642A-4B22-9E44-756C4AD98415Q36327418-CB1395D5-38F9-4567-A14C-2D051D0A4AEFQ36509367-A273D79C-5DF3-43CB-BE51-67443C66E999Q36745955-296E809C-935F-4A08-A46D-7DE9E9E8FE17Q36928167-11DFEFAD-5E8B-4374-9799-8B73F4279BC4Q36987138-73DA322F-47DA-4594-ADD6-CA582FCFC90AQ36996570-7866D237-A091-4029-8F0E-A7D797276055Q37161370-F04693C6-1604-43AF-8878-011BF4379B49Q37540813-8D81CB88-B0CC-4EF3-94C6-786B8873E5F8Q37556263-C30811E6-6BD0-43C6-B908-6B4BA1F3DDB4Q37656860-53148272-9A85-47D1-9A91-F7A497BA35C2Q37663461-E5E2D0F1-7890-4D0A-A988-56CB4F87D0C7Q37990357-B711AB51-3CD6-4887-A520-052250FAB2ABQ38119006-784F29E6-D1E6-41BF-BE61-26F60BC51C32Q38169542-0364085C-E54C-485D-992C-566F9F0E9BDDQ38202898-DA3F1A40-1B5A-4341-8558-CF54B9F987ECQ38254814-7B1F5E49-C88F-43F0-B5B0-9A4681D27CC3Q38333687-862421F8-6AF9-40D5-8E5C-AD51C4577B63Q38560380-B383152E-CF2E-4FFE-A3B0-CA4FC7931654
P2860
Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinical characteristics of me ...... al Poisons Information Service
@ast
Clinical characteristics of me ...... al Poisons Information Service
@en
Clinical characteristics of me ...... al Poisons Information Service
@nl
type
label
Clinical characteristics of me ...... al Poisons Information Service
@ast
Clinical characteristics of me ...... al Poisons Information Service
@en
Clinical characteristics of me ...... al Poisons Information Service
@nl
prefLabel
Clinical characteristics of me ...... al Poisons Information Service
@ast
Clinical characteristics of me ...... al Poisons Information Service
@en
Clinical characteristics of me ...... al Poisons Information Service
@nl
P2093
P2860
P3181
P356
P1476
Clinical characteristics of me ...... al Poisons Information Service
@en
P2093
D J Lupton
J P Thompson
S H L Thomas
P2860
P3181
P356
10.1136/EMJ.2010.096636
P407
P577
2011-08-01T00:00:00Z